Consun Pharmaceutical Group Limited (FRA:C1P)
Germany flag Germany · Delayed Price · Currency is EUR
1.190
+0.260 (27.96%)
Last updated: May 13, 2025

FRA:C1P Statistics

Total Valuation

FRA:C1P has a market cap or net worth of EUR 901.25 million. The enterprise value is 497.71 million.

Market Cap 901.25M
Enterprise Value 497.71M

Important Dates

The next estimated earnings date is Wednesday, May 21, 2025.

Earnings Date May 21, 2025
Ex-Dividend Date Jun 10, 2025

Share Statistics

Current Share Class 831.60M
Shares Outstanding n/a
Shares Change (YoY) +4.12%
Shares Change (QoQ) +5.23%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 409.84M

Valuation Ratios

The trailing PE ratio is 7.48 and the forward PE ratio is 7.01.

PE Ratio 7.48
Forward PE 7.01
PS Ratio 2.30
PB Ratio 1.55
P/TBV Ratio 1.78
P/FCF Ratio 6.96
P/OCF Ratio 6.27
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.92, with an EV/FCF ratio of 3.85.

EV / Earnings 4.13
EV / Sales 1.37
EV / EBITDA 3.92
EV / EBIT 4.18
EV / FCF 3.85

Financial Position

The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.06.

Current Ratio 3.32
Quick Ratio 3.09
Debt / Equity 0.06
Debt / EBITDA 0.26
Debt / FCF 0.27
Interest Coverage 39.17

Financial Efficiency

Return on equity (ROE) is 22.07% and return on invested capital (ROIC) is 13.41%.

Return on Equity (ROE) 22.07%
Return on Assets (ROA) 10.73%
Return on Invested Capital (ROIC) 13.41%
Return on Capital Employed (ROCE) 21.75%
Revenue Per Employee 124,102
Profits Per Employee 38,079
Employee Count 3,164
Asset Turnover 0.52
Inventory Turnover 2.07

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +91.94% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +91.94%
50-Day Moving Average 0.93
200-Day Moving Average 0.84
Relative Strength Index (RSI) 63.84
Average Volume (20 Days) 63

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:C1P had revenue of EUR 392.66 million and earned 120.48 million in profits. Earnings per share was 0.14.

Revenue 392.66M
Gross Profit 296.70M
Operating Income 129.02M
Pretax Income 134.99M
Net Income 120.48M
EBITDA 136.53M
EBIT 129.02M
Earnings Per Share (EPS) 0.14
Full Income Statement

Balance Sheet

The company has 511.55 million in cash and 35.35 million in debt, giving a net cash position of 476.20 million.

Cash & Cash Equivalents 511.55M
Total Debt 35.35M
Net Cash 476.20M
Net Cash Per Share n/a
Equity (Book Value) 581.34M
Book Value Per Share 0.65
Working Capital 420.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 143.84 million and capital expenditures -14.42 million, giving a free cash flow of 129.42 million.

Operating Cash Flow 143.84M
Capital Expenditures -14.42M
Free Cash Flow 129.42M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.56%, with operating and profit margins of 32.86% and 30.68%.

Gross Margin 75.56%
Operating Margin 32.86%
Pretax Margin 34.38%
Profit Margin 30.68%
EBITDA Margin 34.77%
EBIT Margin 32.86%
FCF Margin 32.96%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 11.24%.

Dividend Per Share 0.11
Dividend Yield 11.24%
Dividend Growth (YoY) 98.21%
Years of Dividend Growth 2
Payout Ratio 74.75%
Buyback Yield -4.12%
Shareholder Yield 7.12%
Earnings Yield 13.37%
FCF Yield 14.36%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:C1P has an Altman Z-Score of 4.54.

Altman Z-Score 4.54
Piotroski F-Score n/a